ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing sorted by
relevance

Admin09.10.2021

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing

2307
Admin12.09.2021

(PDF) Mechanistic and Pharmacodynamic studies of ADCT-301

6601
Admin12.09.2021

(PDF) Pre-Clinical Activity of Adct-301, a Novel

Admin12.09.2021

(PDF) ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer

2208
Admin13.08.2021

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing

9907
Admin07.10.2021

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing

Admin18.07.2021

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing

Admin18.09.2021

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing

2904
Admin23.09.2021

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing

5607
Admin23.08.2021

(PDF) ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer

9007
Admin07.09.2021

(PDF) Antistaphylococcal activity of DNA-interactive

8906
Admin25.07.2021

(PDF) Pre-clinical pharmacology and mechanism of action of

7501
Admin24.09.2021

Antibody Drug Conjugates Differentiate Uptake and DNA

200
Admin11.08.2021

Paul PARREN | Executive Vice President and Head of R&D | Ph.D.

8109
Admin25.09.2021

Researchers Evaluate Pyrrolobenzodiazepine(PBD)-dimers

9708
Admin14.07.2021

Exploration of Pyrrolobenzodiazepine (PBD)-Dimers

5102
Admin01.08.2021

Preclinical Evaluation of ADCs Delivering Highly Potent

1007
Admin09.10.2021

A) Schematic diagram of the PBD dimer SJG-136 forming an

6702
Admin09.10.2021

A, averaged mean graphs for the cytotoxicity of SG2285

6705
Admin17.08.2021

QbD in the Development of ADCs with PBD Dimer Warheads

7004
Admin10.08.2021

Peter Hofland, Author at ADC Review ADC Review

708